Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata

Title:	Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
Authors:	King, Brett^Aff1; McMichael, Amy^Aff2; Sinclair, Rodney^Aff3; Vañó-Galvan, Sergio^Aff4; Wolk, Robert^Aff5; Woodworth, Deborah^Aff6; Soma, Koshika^Aff5; Robbana, Feriel^{Aff7, IDs13555025015437_cor1}; Lejeune, Alexandre^Aff8; Napatalung, Lynne^{Aff9, Aff10}; Law, Ernest^Aff9; Wajsbrot, Dalia^Aff5; Wang, Cunshan^Aff5; Roychoudhury, Satrajit^Aff9
Source:	Dermatology and Therapy: Research, treatment and aesthetic interventions in dermatology. 15(12):3793-3803
Database:	Springer Nature Journals